why choose us

First received: November 29, 2022

Clinical Trial: Prolonged Remission Induced by Phenofibrate in Children Newly Diagnosed With Type 1 Diabetes.

Study Status: Completed

Recruit Status: RECRUITING

Condition: Diabetes Mellitus, Type 1

Study Type: INTERVENTIONAL


Official Title: Randomized, Double-blind, Multicenter, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy of Phenofibrate Treatment on the Functions of Beta Cells in Children and Adolescents With Newly

Brief Summary: The goal of this clinical trial is to evaluate of the effect of phenofibrate on the functions of beta cells in children with new diagnosis of type 1 diabetes.The main question it aims to answer is: whether phenofibrate may prolong residual beta-cell function therefore own insulin secretion.Participants will be asked to take a phenofibrate or identically appearing placebo (a neutral substance), orally, once daily, for 12 months with no knowledge what is administred to them.They will be invited for follow-up visits…

Read more